What are the opening hours?

Monday 9am - 5pm Tuesday 9am - 5pm Wednesday 9am - 5pm Thursday 9am - 5pm Friday 9am - 5pm

Akadeum Life Sciences

Name: Akadeum Life Sciences
Address: 674 S Wagner Road, Ann Arbor, MI, 48103, US
Telephone: +17347071233
Price range: $

Home
United States
Ann Arbor, MI
Akadeum Life Sciences

Call Directions Website Contact the business

Akadeum Life Sciences has developed a faster, easier way to separate cells from biological samples by using buoyant microbubbles.

10/31/2026

Some things float, some things sink, and that’s the whole trick. 👻
Our microbubbles rise up and carry off the cells you don’t want, so you keep only the treats. 🧬 🍬
No magnets, no columns, no spooky cell stress. 🎃
Just buoyancy. 🫧
Happy Halloween from Akadeum!

10/27/2026

🎉Did you know you have multiple opportunities to learn and experience microbubbles on Terumo's Quantum Flex™ Cell Expansion System? 🫧

⏲️TODAY: Dr. Cindy Hudachek, Ph.D. of Terumo Blood and Cell Technologies presents a short process that starts from a leukopak and integrates microbubble-based isolation followed by activation, lentiviral transduction, and serum-free expansion.
When: 3 PM ET / 12 PM PT Join the webinar: (https://hubs.li/Q04CsQKY0)

🗓️NEXT WEEK: Advanced Therapies 2026, Boston, MA
➡️November 4, 11:10 a.m., Track 2: Reimagining Gene-Modified T Cell Manufacturing: New Data on Integrating Isolation, Activation, Transduction, and Expansion in a Single Quantum Flex Workflow.

Want to experience a Quantum Flex demo in person?
➡️Stop by Booth #307
Wednesday, November 4, 12:15 p.m.
Thursday, November 5, 12:05 p.m.
Akadeum's Technical Team will be available for questions

We hope to see you soon! 🫧

10/26/2026

🚨TOMORROW!! The Regen Report will host a free webinar presenting the first demonstration of Akadeum's microbubble-based T cell isolation integrated upstream of processing on the Terumo Quantum Flex™ Cell Expansion System. 🫧

Dr. Cindy Hudachek (Terumo Blood and Cell Technologies) will share new data on:
✅ An integrated, closed-system T cell manufacturing workflow
✅ How it compares with traditional transduction methods
✅ Its potential to reduce open handling steps and support process consistency

🫧 Isolation → activation → transduction → expansion, all in one closed workflow.

If you work in CAR-T or cell therapy manufacturing, this is one to catch.

👉 Register: https://hubs.li/Q04BP1rT0

10/22/2026

💡10 million T cells → more than 2 billion in ~8 days. ⚡ Over 90% viability at harvest. One integrated workflow.

Can you consolidate gene-modified T cell manufacturing steps without giving up yield, viability, or cell quality?

On October 27 at 3 p.m. ET, Terumo Blood and Cell Technologies will present a four step process that starts from a leukopak and integrates microbubble-based isolation followed by activation, lentiviral transduction, and serum-free expansion.

Data to be presented includes:
🔹 CD3+ purity >90% with buoyancy-based negative selection 🫧
🔹 Untouched T cells fed directly into the Quantum Flex™ workflow
🔹 Transduction efficiency vs. a manual static-transduction control
🔹 Memory phenotype maintained, with

09/30/2026

For point-of-care cell therapies to succeed, manufacturing needs to be fully closed, automated, and ready to scale from process development into production.

📣We’re excited to share a new preprint showing how Akadeum’s BACS™ microbubble technology performs inside a fully closed, automated CAR-T manufacturing workflow. 🫧

Downstream, CAR-T cells from the selection step matched industry-standard manual methods across key quality metrics, including expansion, transduction, potency, and phenotype, while showing higher metabolic fitness than the conventional control.

Read the preprint to see what gentle, scalable cell selection can unlock for cell therapy manufacturing. 🫧

09/24/2026

⏳ Tomorrow!! We're looking forward to ARM's Q3 Science & Technology / Regulatory CMC Forum.

If you're navigating the tension every cell and gene therapy team knows well — speed vs. quality in manufacturing — this discussion is built for you.

Akadeum's Bill Lloyd, PhD, VP of R&D, will be part of the panel discussing:
"Novel Cell Manufacturing Workflows: Shortening Timelines Without Compromising Quality," alongside:

• Peter Keller, CEO, BlueWhale Bio
• Hannah Song, PhD, NIH Center for Cellular Engineering

Expect candid, practical takeaways from technology partners and clinical developers who've actually implemented these workflows — not just theory.

🗓️ TOMORROW, Friday, September 25, 2026
🕛 12PM ET / 9AM PT
👥 Exclusively for ARM members (check your inbox for session details from ARM)

See you there!

09/16/2026

We're excited to share that Akadeum's Bill Lloyd, PhD, VP of R&D, will join Peter Keller (CEO, BlueWhale Bio) and Hannah Song, PhD (NIH Center for Cellular Engineering) as a panelist for the Alliance for Regenerative Medicine's Q3 Science & Technology / Regulatory CMC Forum!

Topic: "Novel Cell Manufacturing Workflows: Shortening Timelines Without Compromising Quality."

The panel will dig into how novel manufacturing workflows from technology partners and clinical developers are shortening timelines while maintaining — or improving — product quality, with practical lessons from applying these workflows in clinical development.

📅 Friday, September 25, 2026
🕛 12:00 PM ET / 9:00 AM PT
📍 ARM members only — keep an eye on your inbox for session details from ARM.

We're looking forward to a great discussion!

06/03/2026

📣It's almost webinar time!

In an hour you can hear Courtney and Bill discuss:
🫧 How deeply phenotyped donor material helps your research and manufacturing needs
🫧 Why HLA diversity and health-linked metadata strengthens immunogenicity & alloreactivity studies
🫧 How you can leverage negative cell selection to maintain untouched, high-potency cells and preserve native cell biology

TODAY
🕐 1 PM ET / 10 AM PT
Join us: https://hubs.li/Q04jVCdd0

06/02/2026

🚨TOMORROW!

We're looking forward to talking about the importance of understanding your starting material for downstream CGT success, alongside our friends at BioIVT.

🔗Learn how early workflow decisions matter in our webinar tomorrow: https://hubs.li/Q04jf0qF0

05/28/2026

📣Mark your calendars!

📅 Wednesday, June 3
🕐 1 PM ET / 10 AM PT

Upstream decisions have a measurable impact on downstream success in cell and gene therapy.

Join Courtney Noah from BioIVT and Bill Lloyd from Akadeum in this session that will highlight market-leading approaches for donor material qualification and cell isolation, contributors to improved manufacturing workflows.

Learn more, see the data, walk away with a refined approach to your workflow by:
🫧 Leveraging deeply phenotyped donor material to better match research and manufacturing needs
🫧 Using broad HLA diversity (~300 alleles) and health-linked metadata to strengthen immunogenicity and alloreactivity studies
🫧 Preserving native cell biology with negative selection to maintain untouched, high-potency cells

If you’re focused on improving consistency and quality in CGT workflows, this discussion is for you.

Sign up today - even if you cannot attend, we will send you the link:
https://hubs.li/Q04jb8Cx0

Address

674 S Wagner Road
Ann Arbor, MI
48103

Opening Hours

Monday	9am - 5pm
Tuesday	9am - 5pm
Wednesday	9am - 5pm
Thursday	9am - 5pm
Friday	9am - 5pm

Telephone

+17347071233

Website

http://www.akadeum.com/

Alerts

Be the first to know and let us send you an email when Akadeum Life Sciences posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.